FURIEX PHARMACEUTICALS, INC. Retained Earnings
FURIEX PHARMACEUTICALS, INC. had Retained Earnings of -$169.71 million as of 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2014-05-09
- 2014-03-31: Retained Earnings (Accumulated Deficit) -$169.71M.
- 2013-12-31: Retained Earnings (Accumulated Deficit) -$156.66M.
- 2013-09-30: Retained Earnings (Accumulated Deficit) -$150.16M.
- 2013-06-30: Retained Earnings (Accumulated Deficit) -$141.48M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2014-03-31 | -$169.71M 10-Q · filed 2014-05-09 |
| 2013-12-31 | -$156.66M 10-Q · filed 2014-05-09 |
| 2013-09-30 | -$150.16M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$141.48M 10-Q · filed 2013-08-08 |
| 2013-03-31 | -$118.02M 10-Q · filed 2013-05-09 |
| 2012-12-31 | -$126.99M 10-K · filed 2014-03-17 |
| 2012-09-30 | -$117.94M 10-Q · filed 2012-11-06 |
| 2012-06-30 | -$114.65M 10-Q · filed 2012-08-07 |
| 2012-03-31 | -$93.88M 10-Q · filed 2012-05-07 |
| 2011-12-31 | -$84.13M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$77.40M 10-Q · filed 2011-11-10 |
| 2011-06-30 | -$64.39M 10-Q · filed 2011-08-10 |
| 2010-12-31 | -$35.14M 10-K · filed 2012-03-07 |